IL225884A0 - Forms@מוצקות@של@3–@4–@aminomethyl)–1–(5–methyl–7h–pyrrolo [3,2–d] pyrimidine–4–yl)piperidine–4–carboxamido)phenyl dimethylcarbamate - Google Patents
Forms@מוצקות@של@3–@4–@aminomethyl)–1–(5–methyl–7h–pyrrolo [3,2–d] pyrimidine–4–yl)piperidine–4–carboxamido)phenyl dimethylcarbamateInfo
- Publication number
- IL225884A0 IL225884A0 IL225884A IL22588413A IL225884A0 IL 225884 A0 IL225884 A0 IL 225884A0 IL 225884 A IL225884 A IL 225884A IL 22588413 A IL22588413 A IL 22588413A IL 225884 A0 IL225884 A0 IL 225884A0
- Authority
- IL
- Israel
- Prior art keywords
- carboxamido
- pyrrolo
- pyrimidin
- aminomethyl
- piperidine
- Prior art date
Links
- PWPNYABQEOGNNC-UHFFFAOYSA-N [3-[[4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]phenyl] n,n-dimethylcarbamate Chemical compound CN(C)C(=O)OC1=CC=CC(NC(=O)C2(CN)CCN(CC2)C=2C=3C(C)=CNC=3N=CN=2)=C1 PWPNYABQEOGNNC-UHFFFAOYSA-N 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41060210P | 2010-11-05 | 2010-11-05 | |
| PCT/US2011/059086 WO2012061565A1 (en) | 2010-11-05 | 2011-11-03 | Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL225884A0 true IL225884A0 (en) | 2013-07-31 |
Family
ID=45002136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL225884A IL225884A0 (en) | 2010-11-05 | 2013-04-22 | Forms@מוצקות@של@3–@4–@aminomethyl)–1–(5–methyl–7h–pyrrolo [3,2–d] pyrimidine–4–yl)piperidine–4–carboxamido)phenyl dimethylcarbamate |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8735408B2 (enExample) |
| EP (1) | EP2635584A1 (enExample) |
| JP (1) | JP2013541588A (enExample) |
| KR (1) | KR20140003433A (enExample) |
| CN (1) | CN103298815A (enExample) |
| AR (1) | AR083756A1 (enExample) |
| AU (1) | AU2011323371A1 (enExample) |
| BR (1) | BR112013011094A2 (enExample) |
| CA (1) | CA2817112A1 (enExample) |
| IL (1) | IL225884A0 (enExample) |
| MX (1) | MX2013004923A (enExample) |
| RU (1) | RU2013125755A (enExample) |
| SG (1) | SG190098A1 (enExample) |
| TW (1) | TW201302754A (enExample) |
| WO (1) | WO2012061565A1 (enExample) |
| ZA (1) | ZA201302996B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015150337A1 (en) | 2014-04-01 | 2015-10-08 | Amakem Nv | Lim kinase inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI439457B (zh) * | 2007-09-28 | 2014-06-01 | Lexicon Pharmaceuticals Inc | （ｓ）－２－胺基－３－（４－（２－胺基－６－（（ｒ）－１－（４－氯－２－（３－甲基－１ｈ－吡唑－１－基）苯基）－２，２，２－三氟乙氧）－嘧啶－４－基）苯基）丙酸乙酯之固體形式與其使用方法 |
| KR101706391B1 (ko) * | 2008-04-21 | 2017-02-13 | 렉시컨 파마슈티컬스 인코퍼레이티드 | Ｌｉｍｋ2 억제제, 그를 포함하는 조성물 및 그의 사용 방법 |
-
2011
- 2011-11-01 TW TW100139812A patent/TW201302754A/zh unknown
- 2011-11-03 US US13/288,321 patent/US8735408B2/en active Active
- 2011-11-03 RU RU2013125755/04A patent/RU2013125755A/ru not_active Application Discontinuation
- 2011-11-03 JP JP2013537811A patent/JP2013541588A/ja active Pending
- 2011-11-03 KR KR1020137014386A patent/KR20140003433A/ko not_active Withdrawn
- 2011-11-03 MX MX2013004923A patent/MX2013004923A/es not_active Application Discontinuation
- 2011-11-03 WO PCT/US2011/059086 patent/WO2012061565A1/en not_active Ceased
- 2011-11-03 SG SG2013033618A patent/SG190098A1/en unknown
- 2011-11-03 AU AU2011323371A patent/AU2011323371A1/en not_active Abandoned
- 2011-11-03 CN CN2011800533551A patent/CN103298815A/zh active Pending
- 2011-11-03 CA CA2817112A patent/CA2817112A1/en not_active Abandoned
- 2011-11-03 EP EP11785536.1A patent/EP2635584A1/en not_active Withdrawn
- 2011-11-03 BR BR112013011094A patent/BR112013011094A2/pt not_active IP Right Cessation
- 2011-11-04 AR ARP110104111A patent/AR083756A1/es unknown
-
2013
- 2013-04-22 IL IL225884A patent/IL225884A0/en unknown
- 2013-04-24 ZA ZA2013/02996A patent/ZA201302996B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012061565A1 (en) | 2012-05-10 |
| RU2013125755A (ru) | 2014-12-10 |
| AU2011323371A1 (en) | 2013-05-23 |
| CN103298815A (zh) | 2013-09-11 |
| SG190098A1 (en) | 2013-06-28 |
| US8735408B2 (en) | 2014-05-27 |
| ZA201302996B (en) | 2014-06-25 |
| BR112013011094A2 (pt) | 2016-08-23 |
| AR083756A1 (es) | 2013-03-20 |
| CA2817112A1 (en) | 2011-11-05 |
| JP2013541588A (ja) | 2013-11-14 |
| EP2635584A1 (en) | 2013-09-11 |
| TW201302754A (zh) | 2013-01-16 |
| US20120122898A1 (en) | 2012-05-17 |
| KR20140003433A (ko) | 2014-01-09 |
| MX2013004923A (es) | 2013-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2432472T1 (sl) | 3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK | |
| SI3686194T1 (sl) | Spojine 2-(2,4,5-substituiranega-anilino)pirimidina | |
| ZA201008486B (en) | 5-substituted isoindoline compounds | |
| EP2353125A4 (en) | USER AUTHENTICATION FOR SOCIAL NETWORKS | |
| GB201012105D0 (en) | Novel pyrimidine compounds | |
| AP2010005364A0 (en) | Novel heterocyclic compounds. | |
| PL2621903T3 (pl) | Związki n-heteroarylu | |
| EP2699091A4 (en) | 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS | |
| IL257977A (en) | A process for the preparation of 3-(1-amino-2-methylpentane-3-yl)substituted phenyl compounds | |
| ZA201301385B (en) | Therapeutic uses of 1-[2,4-dimethyl-phenylsulfanyl)phenyl]piperazine | |
| IL214110A0 (en) | 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds | |
| PT2523963E (pt) | Derivados de oxazolopirimidina substituídos em 2,5 como agonistas do edg-1 | |
| ZA201302996B (en) | Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate | |
| HK1196618B (en) | 3-(pyrimidin-4-yl)-oxazolidin-2-ones as inhibitors of mutant idh | |
| HK1184434B (en) | Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds | |
| PL393096A1 (pl) | Sposób otrzymywania nowych związków - pochodnych 3-[5,5-bis(piwaloiloksymetylo)pirolidyn-2-ylo]-1H-indolu | |
| HK1188394A (en) | Formulations of phenyl uracil compounds | |
| GB201009514D0 (en) | Novel heterocyclic compounds | |
| GB201021416D0 (en) | Novel heterocyclic compounds | |
| AU2012900131A0 (en) | "Heterocyclic compounds" |